NCT01749592

Brief Summary

  • As the left and right hemisphere are specialized for different auditory tasks, the proposed study aims at demonstrating different consequences of right or left-sided deafness for the affected individual.
  • Furthermore, the question should be answered if auditory deficits and plastic changes can be partially reversed by cochlear implantation of the deaf ear.
  • Multicenter, prospective, open, non-randomized clinical trial with 5 patients with right-sided and 5 patients with left-sided sensineural deafness.
  • Pre-operative: Audiometry, Sound Localization Audiometry, PET, EEG/MEG
  • Comparison of pre-operative investigations with 10 healthy subjects (age and gender matched control group)
  • Cochlea implantation
  • Follow-up Visits at 3, 6, 9 and 12 month post-operative: Audiometry, Sound Localization Audiometry, PET, EEG, Questionnaires
  • Trial with medical device

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2012

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

December 11, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 13, 2012

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 8, 2018

Completed
Last Updated

September 9, 2020

Status Verified

September 1, 2020

Enrollment Period

5.1 years

First QC Date

December 11, 2012

Last Update Submit

September 3, 2020

Conditions

Keywords

hearing losscochlear implantPETEEGMEG

Outcome Measures

Primary Outcomes (1)

  • Audiometry

    Pure tone audiometry Speech audiometry Sound localization in both quiet and noise

    up to12 months after invention

Secondary Outcomes (1)

  • PET scan

    9 months after intervention

Other Outcomes (1)

  • EEG

    3, 6 and 12 months after intervention

Study Arms (1)

Cochlear Implant

EXPERIMENTAL

Surgical Implantation of a Cochlear Implant

Device: cochlear implant

Interventions

Surgical implantation of a cochlear implant device

Cochlear Implant

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: 18-70 years old.
  • Normal hearing on the contralateral ear (Hearing thresholds 0.125-2 kHz 25 dB HL or better, 4-8 kHz 35 dB HL or better, 100% speech discrimination at 80 dB SPL).
  • Regular middle ear function on the hearing ear.
  • Regular structure of the cochlea and the cochlear nerve (as demonstrated by MRI, MRI scans are included in the basic assessment of SSD and are no study-specific investigations).
  • Fluency in the German language.
  • Subject is willing to comply with all study requirements.
  • Impairment in daily life as a consequence of SSD (communication problems, annoyance by tinnitus perception).
  • Subject is not participating in another ongoing research study related to the SSD.
  • Subject does not have unrealistic expectations, regarding the outcome of the intervention.
  • Subject has had a trial with conventional acoustic measures in SSD (CROSS, BAHA).

You may not qualify if:

  • Retrocochlear cause of SSD (Deafness due to lesions of the acoustic nerve or central auditory pathways).
  • Active middle ear infections.
  • Ossification of the cochlear that prevents electrode insertion.
  • Tympanic membrane perforation.
  • Psychiatric comorbidities such as depression or cognitive deficits.
  • Severe coexisting illness with a medium survival of less than 5 years.
  • Exposure to radiation with a cumulative effective dose of 5 mSV within the last 5 years (including the ongoing year).
  • Increased risk profile for general anesthesia due to cardiovascular comorbidity.
  • Pregnancy (a pregnancy test will be performed in women in the reproductive age group before study enrolment and before postoperative PET scan) and lactation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Zurich, Division of Otorhinolaryngology ORL

Zurich, Canton of Zurich, 8091, Switzerland

Location

Related Publications (2)

  • Peter N, Treyer V, Probst R, Kleinjung T. Auditory Cortical Plasticity in Patients with Single-Sided Deafness Before and After Cochlear Implantation. J Assoc Res Otolaryngol. 2024 Feb;25(1):79-88. doi: 10.1007/s10162-024-00928-3. Epub 2024 Jan 22.

  • Peter N, Kleinjung T, Probst R, Hemsley C, Veraguth D, Huber A, Caversaccio M, Kompis M, Mantokoudis G, Senn P, Wimmer W. Cochlear implants in single-sided deafness - clinical results of a Swiss multicentre study. Swiss Med Wkly. 2019 Dec 27;149:w20171. doi: 10.4414/smw.2019.20171. eCollection 2019 Dec 16.

MeSH Terms

Conditions

Hearing Loss, SensorineuralHearing Loss

Interventions

Cochlear Implants

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Neural ProsthesesImplantable NeurostimulatorsElectrodes, ImplantedElectrodesElectrical Equipment and SuppliesEquipment and SuppliesProstheses and ImplantsHearing AidsSensory Aids

Study Officials

  • Tobias Kleinjung, MD

    University Hospital Zurich, Division of Otorhinolaryngology ORL

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 11, 2012

First Posted

December 13, 2012

Study Start

December 1, 2012

Primary Completion

January 1, 2018

Study Completion

February 8, 2018

Last Updated

September 9, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations